Biocept Secures In-Network Provider Agreement with Blue Cross Blue Shield of Texas Medical Device Investing
Cancer Genetics, Inc. Announces Consolidation and Cost Reduction in Administrative and Operational Support Functions Medical Device Investing
RespireRx Pharmaceuticals Inc. to Present at 9th Annual Biotech Showcase(TM) 2017 Medical Device Investing
MRI Interventions’ ClearPoint® Surpasses Single-Year Milestone of 500 Procedures in 2016 Medical Device Investing
